SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-027979
Filing Date
2019-05-09
Accepted
2019-05-09 06:27:50
Documents
46
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7743_110q.htm 10-Q 525415
2 EX-31.1 a19-7743_1ex31d1.htm EX-31.1 10772
3 EX-31.2 a19-7743_1ex31d2.htm EX-31.2 10745
4 EX-32.1 a19-7743_1ex32d1.htm EX-32.1 7070
11 GRAPHIC g77431bai001.jpg GRAPHIC 1598
  Complete submission text file 0001104659-19-027979.txt   2542283

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rarx-20190331.xml EX-101.INS 486691
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rarx-20190331.xsd EX-101.SCH 23942
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rarx-20190331_cal.xml EX-101.CAL 40207
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rarx-20190331_def.xml EX-101.DEF 47920
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rarx-20190331_lab.xml EX-101.LAB 231227
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rarx-20190331_pre.xml EX-101.PRE 154767
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37926 | Film No.: 19808674
SIC: 2834 Pharmaceutical Preparations